4-Bromothiazole → HCID 67371743, compound
Reaction equation
[CH3:1][C@@H:2]1[CH2:7][NH:6][CH2:5][CH2:4][NH:3]1.Br[C:9]1[N:10]=[CH:11][S:12][CH:13]=1>Cl>[CH3:1][C@H:2]1[NH:3][CH2:4][CH2:5][N:6]([C:9]2[N:10]=[CH:11][S:12][CH:13]=2)[CH2:7]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
10.0 g (100 mmol) (R)-2-methylpiperazine were fused at 100° C. 2.7 g (16.8 mmol) 4-bromothiazol was added in portions to this fusion over a period of 2 h. Stirring was subsequently performed for 18 h at 100° C. After cooling to RT, the residue was received in 10% aq. hydrochloric acid and washed with AE. Alkalic adjustment was subsequently performed with a 10% aq. NaOH sol. (pH>12) and extracted with DCM. The organic phase was dried over MgSO4, filtered and concentrated in a vacuum. CC (SiO2, DCM/MeOH 9:1) was performed with the residue, whereby 277 mg (1.5 mmol, 9%) (R)-4-(3-methylpiperazine-1-yl)thiazol was obtained.
Workup
- customwere fused at 100° C
- washwashed with AE
- extractionextracted with DCM
- dry with materialThe organic phase was dried over MgSO4
- filtrationfiltered
- concentrationconcentrated in a vacuum
Sources & evidence
- ORD record
- ord-7123b236033448519e61f1eec9239a77
- Source dataset
- uspto-grants-2011_08
- Patent number
- US08008304B2
Reaction notes
Loading…